Get notified when JAGX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Delisting (new) — Company faces immediate delisting risk without grace period if stock falls below $1.00 for 30 days during one-year monitoring period.
Jaguar Health regains Nasdaq compliance but faces strict one-year monitoring with no grace period
Filed May 27, 2026 · Period ending May 26, 2026 · ~1 min read
Key Changes
-
high
Company regained compliance with Nasdaq's $1.00 minimum bid price requirement on May 26, 2026, after receiving a Decision Letter from the Nasdaq Hearings Panel following an appeal process.
Item 8.01 verify on EDGAR → -
high
Nasdaq imposed a mandatory one-year monitoring period through May 26, 2027, during which the Panel will maintain heightened oversight of the company's listing status through September 1, 2026.
Item 8.01 verify on EDGAR → -
high
If the stock trades below $1.00 for 30 consecutive business days during the monitoring period, Nasdaq will immediately issue a delisting determination without the standard 180-day grace period normally available.
Item 8.01 verify on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade JAGX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · May 27, 2026 · How we verify